These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 25014558)
1. Heterotopic ossification after transforaminal lumbar interbody fusion without bone morphogenetic protein use. Wagner SC; Kang DG; Helgeson MD Spine J; 2014 Nov; 14(11):2783-4. PubMed ID: 25014558 [No Abstract] [Full Text] [Related]
2. Heterotopic ossification associated with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral lumbar spine fusion: a case report. Anderson CL; Whitaker MC Spine (Phila Pa 1976); 2012 Apr; 37(8):E502-6. PubMed ID: 22020605 [TBL] [Abstract][Full Text] [Related]
3. Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion. Christensen TJ; Annis P; Hohl JB; Patel AA Spine J; 2014 Jun; 14(6):e23-8. PubMed ID: 24291359 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2. Lehman RA; Kang DG Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741 [No Abstract] [Full Text] [Related]
5. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost? Mannion RJ; Nowitzke AM; Wood MJ Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225 [TBL] [Abstract][Full Text] [Related]
6. Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine. Chrastil J; Low JB; Whang PG; Patel AA Spine (Phila Pa 1976); 2013 Jul; 38(16):E1020-7. PubMed ID: 23629484 [TBL] [Abstract][Full Text] [Related]
7. Pseudo-Pedicle Heterotopic Ossification From Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Transforaminal Lumbar Interbody Fusion Cages. Rosen CD; Kiester PD; Lee TQ Am J Orthop (Belle Mead NJ); 2018 Jan; 47(1):. PubMed ID: 29447305 [TBL] [Abstract][Full Text] [Related]
8. Brower RS, Vickrov NM. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Spine 2008;33:E653-55. Dickerman RD; Reynolds AS; Bennett M Spine (Phila Pa 1976); 2009 Apr; 34(7):749; author reply 749. PubMed ID: 19333110 [No Abstract] [Full Text] [Related]
9. Complications associated with posterior and transforaminal lumbar interbody fusion. Chrastil J; Patel AA J Am Acad Orthop Surg; 2012 May; 20(5):283-91. PubMed ID: 22553100 [TBL] [Abstract][Full Text] [Related]
10. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763 [TBL] [Abstract][Full Text] [Related]
11. Polyelectrolyte Complex Carrier Enhances Therapeutic Efficiency and Safety Profile of Bone Morphogenetic Protein-2 in Porcine Lumbar Interbody Fusion Model. Wang M; Abbah SA; Hu T; Lam RW; Toh SY; Liu T; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK Spine (Phila Pa 1976); 2015 Jul; 40(13):964-73. PubMed ID: 25893351 [TBL] [Abstract][Full Text] [Related]
12. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Joseph V; Rampersaud YR Spine (Phila Pa 1976); 2007 Dec; 32(25):2885-90. PubMed ID: 18246013 [TBL] [Abstract][Full Text] [Related]
13. Ectopic bone formation with joint impingement after posterior lumbar fusion with rhBMP-2. Bannwarth M; Kleiber JC; Marlier B; Eap C; Duntze J; Litre CF Orthop Traumatol Surg Res; 2016 Apr; 102(2):255-6. PubMed ID: 26947733 [TBL] [Abstract][Full Text] [Related]
14. Lumbar paraspinal heterotopic ossification. Kang DG; Potter BK; Lehman RA Spine J; 2012 Jul; 12(7):631-3. PubMed ID: 22749653 [No Abstract] [Full Text] [Related]
15. Lumbar interbody fusion with utilization of recombinant human bone morphogenetic protein: a retrospective real-life study about 277 patients. Litrico S; Langlais T; Pennes F; Gennari A; Paquis P Neurosurg Rev; 2018 Jan; 41(1):189-196. PubMed ID: 28281191 [TBL] [Abstract][Full Text] [Related]
16. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Brower RS; Vickroy NM Spine (Phila Pa 1976); 2008 Aug; 33(18):E653-5. PubMed ID: 18708918 [TBL] [Abstract][Full Text] [Related]
17. Symptomatic calcified perineural cyst after use of bone morphogenetic protein in transforaminal lumbar interbody fusion: a case report. Than KD; Rahman SU; McKeever PE; Wang AC; La Marca F; Park P Spine J; 2013 Aug; 13(8):e31-5. PubMed ID: 23792101 [TBL] [Abstract][Full Text] [Related]
18. Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion. Aichmair A; Girardi FP; Hughes AP; Sama AA; Lebl DR; Cammisa FP Spine J; 2013 Oct; 13(10):1411-2. PubMed ID: 24139750 [No Abstract] [Full Text] [Related]
19. Minimally Invasive Transforaminal Lumbar Interbody Fusion and Unilateral Fixation for Degenerative Lumbar Disease. Wang HW; Hu YC; Wu ZY; Wu HR; Wu CF; Zhang LS; Xu WK; Fan HL; Cai JS; Ma JQ Orthop Surg; 2017 Aug; 9(3):277-283. PubMed ID: 28960820 [TBL] [Abstract][Full Text] [Related]
20. Increased incidence of pseudarthrosis after unilateral instrumented transforaminal lumbar interbody fusion in patients with lumbar spondylosis: Clinical article. Gologorsky Y; Skovrlj B; Steinberger J; Moore M; Arginteanu M; Moore F; Steinberger A J Neurosurg Spine; 2014 Oct; 21(4):601-7. PubMed ID: 25084031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]